Expression of cyclooxygenase-2 has no impact on survival in adenocarcinoma of the esophagogastric junction but is associated with favourable clinicopathologic features.
Journal article published in 2017 by
J. Knief,
K. Reddemann,
E. Petrova,
T. Herhahn,
U. Wellner 
,
C. Thorns
,
C. Thorns
